• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

H Lundbeck A/S

+ Add to Watchlist


130.1000 DKK 1.0000 0.77%

As of 07:48:03 ET on 10/31/2014.

Snapshot for H Lundbeck A/S (LUN)

Open: 129.8000 Day's Range: 128.4000 - 130.6000 Volume: 44,638
Previous Close: 129.1000 52wk Range: 111.5000 - 173.6000 1-Yr Rtn: +11.55%

Stock Chart for LUN

No chart data available.
  • LUN:DC 129.6000
  • 1D
  • 1M
  • 1Y
Interactive LUN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LUN

Current P/E Ratio (ttm) 33.4523
Estimated P/E(12/2014) 38.5411
Relative P/E vs. KFX 1.5232
Earnings Per Share (DKK) (ttm) 3.8981
Est. EPS (DKK) (12/2014) 3.3860
Est. PEG Ratio -
Market Cap (M DKK) 25,608.15
Shares Outstanding (M) 196.38
30 Day Average Volume 192,876
Price/Book (mrq) 1.8987
Price/Sale (ttm) 1.7928
Dividend Indicated Gross Yield 2.12%
Cash Dividend (DKK) 2.7700
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 3.79%
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LUN

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for LUN

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Thorleif KrarupDeputy ChairmanUlf WiinbergPresident/CEO
Anders GotzscheExec VP/CFOAnders Gersel PedersenExec VP:Research & Dev
More Company Profile & Key Executives for LUN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil